A publicly funded 23vPPV (23 valent pneumococcal polysaccharide vaccine) program in Victoria, Australia not only dramatically increased vaccination coverage among the elderly in the public purchase program, but in other Australian states and territories that did not have a public program, the number of prescriptions issued for 23vPPV actually increased over the same period.
Full Citation:
Andrews, R.M.. 2005. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine. 23(21).
Title of Article: Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia
Author(s): Andrews, R.M.
Publication Year: 2005
Publication Name: Vaccine
Publication Volume: 23(21)
Publication Source URL: https://pubmed.ncbi.nlm.nih.gov/15780723/
DOI (Digital Object Identifier): 10.1016/j.vaccine.2004.11.039
Topics: Equity
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Immunization Terms: Equity
Countries: Australia
WHO Regions: Western Pacific